Enzo Biochem CEO and leadership

Elazar has worked as Chairman/CEO/Founder at ENZO BIOCHEM INC. He works or has worked as MEMBER at American Society for Microbiology. Elazar attended Columbia University and New York University.

David Bench is President of DBC Group Corp., a financial advisory and consultancy company based in New York. DBC assists public and private global corporations with fundamental analysis, outsourced CFO services, document preparation (PPMs, Financial Modeling, Business Plans & Investor Presentations), and funding resources. DBC provides in depth qualitative and quantitative analysis of small-cap and micro-cap companies as well as acting in an advisory role to many of these businesses. Additionally, DBC acts as a liaison for investment purposes between Investment Banks, Venture Capital / Private Equity firms, and the corporations it may represent.

Mr. Bench was previously a Vice President of Institutional Equity Research at Arnhold and S. Bleichroeder in New York. His coverage included the U.S. telecom and technology sectors, with a focus on the former Regional Bell Operating Companies (RBOCs), security software and Internet infrastructure. Prior to joining the firm, Mr. Bench worked in Mergers & Acquisitions within the Investment Banking division of Lazard Fréres L.L.C. Mr. Bench received his Bachelor’s degree from Brandeis University and his Master’s degree in Finance from the International Business School at Brandeis.

Mr. Bench is FINRA Series 7, 63, 79, 86, & 87 certified.

About The DBC Group

The DBC Group has been providing advisory, consultancy, and financial support services to a select client base since 2002. Located in midtown Manhattan, the Company assists both public and private corporations with analysis, financial marketing, outsourced CFO capabilities, and business development.

DBC Group's mission is to enable private and small public companies to reach their financial, investor, and business development goals. The company operates under four unwavering principals: integrity, passion, accuracy, and focus.

Specialties: Specialties include: Due Diligence, Equity Research, Mergers and Acquisitions, Corporate Financial Advisory, Public Company Analysis, Financial Marketing, Investment Banking Support, Business Development, Microcap

Tasks include: Deal Structuring, Financial Modeling & Analysis, Business Plans, Private Placement Memorandums (PPMs), Research Reports, PowerPoint Presentations

Industries include: technology, telecom, consumer, media, airlines, energy. Small Cap, smallcap, Micro Cap, microcap.

Elazar has worked as Chairman/CEO/Founder at ENZO BIOCHEM INC. He works or has worked as MEMBER at American Society for Microbiology. Elazar attended Columbia University and New York University.